Today is

Department of

Surgery

Photo of  Simon Tremblay, PharmD, PhD, BCPS

Simon Tremblay, PharmD, PhD, BCPS

Research Assistant Professor; Director of Transplant Antihumoral Therapies Program

Education/Credentials
  • Bachelor's Degree: Université de Montréal, Montréal, Canada
  • Master's Degree: Université de Montréal, Montréal, Canada
  • Doctor of Pharmacy Degree: University of British Columbia, Canada
  • Solid Organ Transplant Fellowship: University of Cincinnati Medical Center
  • Doctor of Philosophy Degree in Epidemiology: University of Cincinnati
Contact Information
  • Medical Sciences Building
  • 231 Albert Sabin Way
  • Cincinnati, Ohio 45267-0519
  • Office 513-558-9967
  • Email tremblsn@ucmail.uc.edu

Peer Reviewed Publications

Lichvar, Alicia; Tremblay, Simon; Naik, Devanshi; Lipscomb, Jessi; King, Eileen; Vinks, Alexander A; Christians, Uwe; Alloway, Rita R 2019. Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients. Pharmacotherapy, ,

Abu Jawdeh, Bassam G; Woodle, Ervin Steve; Leino, Abbie D; Brailey, Paul; Tremblay, Simon; Dorst, Tonya; Abdallah, Mouhamad H; Govil, Amit; Byczkowski, Daniel; Misra, Hemant; Abuchowski, Abraham; Alloway, Rita R 2018. A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. Clinical transplantation, 32 1,

Alloway, Rita R; Vinks, Alexander A; Fukuda, Tsuyoshi; Mizuno, Tomoyuki; King, Eileen C; Zou, Yuanshu; Jiang, Wenlei; Woodle, E Steve; Tremblay, Simon; Klawitter, Jelena; Klawitter, Jost; Christians, Uwe 2017. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial. PLoS medicine, 14 11, e1002428

Tremblay, Simon; Alloway, Rita R 2017. Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. The AAPS journal, 19 5, 1332-1347

Woodle, E Steve; Tremblay, Simon; Driscoll, James 2017. Targeting Plasma Cells with Proteasome Inhibitors: Principles from Primates. Journal of the American Society of Nephrology : JASN, 28 7, 1951-1953

Woodle, E Steve; Tremblay, Simon; Driscoll, James J 2017. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. The New England journal of medicine, 377 17, 1692-3

Paterno, Flavio; Girnita, Alin; Brailey, Paul; Witte, David; Wang, Jiang; Cuffy, Madison C; Diwan, Tayyab; Tremblay, Simon; Revollo, Jane Y; Alloway, Rita R; Schoech, Michael R; Anwar, Nadim; Shah, Shimul A; Woodle, Steve E 2016. Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA Antibodies. Transplantation direct, 2 12, e121

Tremblay, Simon; Kaiser, Tiffany E; Alloway, Rita R; Woodle, E Steve; Diwan, Tayyab S 2016. Absence of the Effect of Pretransplant Body Mass Index on Post Kidney Transplant Outcomes. Progress in transplantation (Aliso Viejo, Calif.), 26 2, 183-90

Verret, Lucie; Couturier, Justine; Rozon, Andréanne; Saudrais-Janecek, Sarah; St-Onge, Amélie; Nguyen, Angela; Basmadjian, Arsène; Tremblay, Simon; Brouillette, Denis; de Denus, Simon 2012. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial. Pharmacotherapy, 32 10, 871-9

Borie D.; Brunetta P.; Busque S.; Cascino M.; Desai N.; Formica R.; Green C.; Jamois C.; Jordan S.; Looney C.; Morimoto A.; Rajwanshi R.; Redfield R.; Reed E.; Schindler T.; Schroeder A.; Tran H.; Tremblay S.; Vincenti F.; Vo A.; Woodle E.; Zachary A. 11-01-2019. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclona American Journal of Transplantation, 19 11, 3035-3045

Alloway R.; Nigro V.; Tremblay S.; Woodle E. 06-01-2017. Reply to “Fluctuation Does Not Mean Variability: A Pharmacokinetic Point of View” American Journal of Transplantation, 17 6, 1693

Basmadjian A.; Brouillette D.; De Denus S.; Justine Couturier; Nguyen A.; Rozon A.; Saudrais-Janecek S.; St-Onge A.; Tremblay S.; Verret L. 04-01-2013. Erratum: Impact of a pharmacist-led warfarin self-management program on quality of life and anticoag Pharmacotherapy, 33 4, 464

Alloway R.R.; Aronow B.; Brailey P.; Dasgupta N.; Driscoll J.J.; Ebstein F.; Girnita A.; Kim K.B.; Kloetzel P.M.; Lee M.J.; Singh H.; Tremblay S.; Woodle E.S. 02-01-2020. Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells American Journal of Transplantation, 20 2, 399-410

Alloway R.R.; Brailey P.A.; Driscoll J.J.; Girnita A.L.; Hildeman D.A.; Rike-Shields A.; Tremblay S.; Woodle E.S. 02-01-2020. A prospective, iterative, adaptive trial of carfilzomib-based desensitization American Journal of Transplantation, 20 2, 411-421

Alloway R.; Nigro V.; Tremblay S.; Weinberg J.; Woodle E. 02-01-2017. A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTC American Journal of Transplantation, 17 2, 432-442

Alloway R.R.; Brailey P.; Bruno K.; Cicerchi J.; Cline A.; Dorst T.; Farnsworth M.; Fernandez D.A.; Girnita A.; Kaufman D.B.; King E.C.; Leone J.; Lipscombe J.; Matas A.; Naciff-Stahl A.; Rohan J.; Sa T.; Schneider K.; Shields A.R.; Stucke A.; Thomas J.; Tremblay S.; West-Thielke P.; Wiseman A.; Woodle E.S. 01-01-2019. Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corti American Journal of Transplantation, ,

Campara M.; Ensor C.; Hofmeyer B.; Lushin E.; Potter L.; Tremblay S.; Wilson N. 01-01-2019. Discharge medication procurement and education after kidney transplantation Clinical Transplantation, 33 8,

Tremblay, Simon; Lau, Tim T Y; Ensom, Mary H H . Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence? The Annals of pharmacotherapy, 47 7-8, 1045-54